This research aims to evaluate the success of hepatitis B treatment and identify factors that influence treatment outcomes in Rwanda.
Population-based analysis of HBV treatment records in Rwanda
Comparison of treatment success rates between individuals with and without HBV/HCV co-infection
Assessment of cirrhosis impact on treatment effectiveness
HBV treatment success was generally high among the population
Lower success rates were observed in individuals with HBV/HCV co-infection
Cirrhosis was associated with reduced treatment response, emphasizing the need for monitoring
Abstract
HBV treatment success in Rwanda was high but lower in those with HBV/HCV co-infection or cirrhosis, underscoring the need for early detection and monitoring.